IxioLabs is a biotech company focused on the research and development of integrative biological systems. We employ a wide range of techniques, from computational to in vivo models. Our primary goal is to generate specific protocols to complete comprehensive models, that could be exploited to simulate, monitor, diagnose, and predict physiopathological states, among other applications. In addition, IxioLabs offers cutting-edge services on big data analysis and cell-based studies to other companies, laboratories and hospitals.